Table 3.
Univariate Analysis | Multivariate Analysis | |||
---|---|---|---|---|
Variables | HR (95% CI) | p | HR (95% CI) | p |
Age at diagnosis | 0.978 (0.941–1.016) | 0.260 | ||
Sex | 0.425 (0.146–1.233) | 0.115 | ||
Etiology | 0.869 (0.586–1.287) | 0.483 | ||
Varices | 1.142 (0.455–2.868) | 0.777 | ||
PVT | 1.346 (0.568–3.186) | 0.500 | ||
HCC grade | 1.141 (0.736–1.769) | 0.556 | ||
Extra-hepatic localization * | 1.982 (0.928–4.237) | 0.077 | ||
Time on TKIs | 0.950 (0.911–0.990) | 0.015 | 0.944 (0.893–0.998) | 0.043 |
Tumoral Ang2 | 1.334 (0.025–71.640) | 0.887 | ||
Endothelial Ang2 | 0.253 (0.002–35.210) | 0.586 | ||
LEC podoplanin * | 0.027 (0.001–0.876) | 0.042 | 0.009 (0.000–0.842) | 0.042 |
Tumoral CLEC-2 | 0.641 (0.009–47.284) | 0.840 | ||
Bilirubin | 0.835 (0.585–1.191) | 0.320 | ||
INR | 0.637 (0.041–9.826) | 0.747 | ||
Albumin | 0.762 (0.290–2.007) | 0.583 | ||
Creatinine | 0.970 (0.257–3.657) | 0.965 | ||
Platelets | 1.000 (1.000–1.000) | 0.189 | ||
AFP | 1.000 (1.000–1.000) | 0.408 |
* Collinear with LEC podoplanin.